Drugs Made In America Acquisition Corp. (DMAA)
NASDAQ: DMAA · Real-Time Price · USD
10.84
+0.04 (0.37%)
Sep 14, 2026, 12:22 PM EDT - Market open
DMAA Market Cap
DMAA has a market cap or net worth of $263.16 million as of September 14, 2026. Its market cap has decreased by -23.77% in one year.
Market Cap
263.16M
Enterprise Value
263.49M
1-Year Change
-23.77%
Ranking
Category
Stock Price
$10.84
ChartMarket Cap Chart
Since the IPO on January 28, 2025, DMAA's market cap has decreased from $291.71M to $263.16M, a decrease of -9.79%. That is a compound annual growth rate of -6.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 263.16M | -24.32% |
| Dec 30, 2025 | 347.71M | 19.20% |
| Jan 28, 2025 | 291.71M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Catalyst Acquisition | 271.70M |
| Dynamix Corporation III | 270.21M |
| Karman Line Acquisition | 268.25M |
| Oaktree Acquisition Corp. III Life Sciences | 264.26M |
| Newbury Street II Acquisition | 262.87M |
| FACT II Acquisition | 260.72M |
| TRG Latin America Acquisitions | 259.11M |
| Vendome Acquisition Corporation I | 257.50M |